BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 2277972)

  • 21. New drugs. H2 receptor antagonists--cimetidine and ranitidine.
    Feely J; Wormsley KG
    Br Med J (Clin Res Ed); 1983 Feb; 286(6366):695-7. PubMed ID: 6130817
    [No Abstract]   [Full Text] [Related]  

  • 22. Effect of ranitidine and cimetidine on gastric ulcer healing and recurrence.
    Dawson J; Jain S; Cockel R
    Scand J Gastroenterol; 1984 Jul; 19(5):665-8. PubMed ID: 6089305
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Controlled comparison of ranitidine and cimetidine in patients of duodenal ulcer, gastric ulcer and reflux esophagitis: a multicentre study.
    Anand BS; Balakrishnan V; Desai D; Habibullah CM; Joshi VG; Kalro RH; Misra RC; Nigam DK; Parikh KN; Puri DS
    Indian J Gastroenterol; 1986 Oct; 5 Suppl():29-33. PubMed ID: 3539782
    [No Abstract]   [Full Text] [Related]  

  • 24. Maintenance therapy of duodenal ulcer with H2-receptor antagonists--a meta-analysis.
    Palmer RH; Frank WO; Karlstadt R
    Aliment Pharmacol Ther; 1990 Jun; 4(3):283-94. PubMed ID: 1983324
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An evaluation of cimetidine and ranitidine in the pain relief and acute healing of duodenal ulcer disease.
    Young MD; Lottes SR; Webb LA
    Clin Ther; 1988; 10(5):543-52. PubMed ID: 2856597
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Approaches to healing and prophylaxis of nonsteroidal anti-inflammatory drug-associated ulcers.
    Yeomans ND
    Am J Med; 2001 Jan; 110(1A):24S-28S. PubMed ID: 11165992
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Histamine2-receptor antagonists in gastroduodenal ulcer haemorrhage.
    Falk A; Darle N; Haglund U; Törnqvist A
    Scand J Gastroenterol Suppl; 1985; 110():95-100. PubMed ID: 2862700
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical review of histamine2 receptor antagonists.
    Lipsy RJ; Fennerty B; Fagan TC
    Arch Intern Med; 1990 Apr; 150(4):745-51. PubMed ID: 1970232
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy of the H+/K+-adenosine triphosphatase inhibitor omeprazole in peptic ulcer.
    de Bruijne JW; Snel P; Lamers CB
    Digestion; 1989; 44 Suppl 1():25-30. PubMed ID: 2691308
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influence of sex and Helicobacter pylori on development and healing of gastroduodenal lesions in non-steroidal anti-inflammatory drug users.
    Hawkey CJ; Wilson I; Naesdal J; Långström G; Swannell AJ; Yeomans ND
    Gut; 2002 Sep; 51(3):344-50. PubMed ID: 12171954
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Controlled comparison of ranitidine and cimetidine in patients of duodenal ulcer, gastric ulcer and reflux esophagitis: a multicentre study.
    Indian J Gastroenterol; 1986 Oct; 5 Suppl():35-44. PubMed ID: 3539783
    [No Abstract]   [Full Text] [Related]  

  • 32. Effect of treatment of Helicobacter pylori infection on the long-term recurrence of gastric or duodenal ulcer. A randomized, controlled study.
    Graham DY; Lew GM; Klein PD; Evans DG; Evans DJ; Saeed ZA; Malaty HM
    Ann Intern Med; 1992 May; 116(9):705-8. PubMed ID: 1558340
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ranitidine in the treatment of gastric and duodenal ulcers associated with non-steroidal anti-inflammatory drugs.
    Tildesley G; Ehsanullah RS; Wood JR
    Br J Rheumatol; 1993 Jun; 32(6):474-8. PubMed ID: 8508283
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cimetidine, ranitidine and mifentidine in specific gastric and duodenal ulcer models.
    Del Soldato P; Ghiorzi A; Cereda E; Donetti A
    Pharmacology; 1985; 30(1):45-51. PubMed ID: 2858110
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of peptic ulcer induced by non-steroidal anti-inflammatory drugs.
    Malchow-Møller A
    Scand J Gastroenterol Suppl; 1987; 127():87-91. PubMed ID: 3303297
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Famotidine in the treatment of gastric and duodenal ulceration: overview of clinical experience.
    Bianchi Porro G
    Digestion; 1985; 32 Suppl 1():62-9. PubMed ID: 2866137
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ulcer healing and relapse prevention by ranitidine in peptic ulcer disease.
    Liedberg G; Davies HJ; Enskog L; Eriksson S; Frederiksen B; Graffner H; Hradsky M; Oscarson J; Rydberg B; Simert G
    Scand J Gastroenterol; 1985 Oct; 20(8):941-4. PubMed ID: 3909374
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevention of gastric ulcer relapse induced by indomethacin in rats by a mutein of basic fibroblast growth factor.
    Satoh H; Asano S; Maeda R; Murakami I; Inada I; Sato F; Shino A
    Jpn J Pharmacol; 1997 Mar; 73(3):229-41. PubMed ID: 9127818
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Randomised study of the influence of non-steroidal anti-inflammatory drugs on the treatment of peptic ulcer in patients with rheumatic disease.
    Manniche C; Malchow-Møller A; Andersen JR; Pedersen C; Hansen TM; Jess P; Helleberg L; Rasmussen SN; Tage-Jensen U; Nielsen SE
    Gut; 1987 Feb; 28(2):226-9. PubMed ID: 3549473
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ranitidine in the prevention of gastric and duodenal ulcer relapse.
    Alstead EM; Ryan FP; Holdsworth CD; Ashton MG; Moore M
    Gut; 1983 May; 24(5):418-20. PubMed ID: 6301956
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.